trending Market Intelligence /marketintelligence/en/news-insights/trending/A_ZJfZdq2rxrfEUNxD4jTw2 content esgSubNav
In This List

US FDA clears ZELTIQ's fat-removal treatment for upper arms

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


US FDA clears ZELTIQ's fat-removal treatment for upper arms

The U.S. FDA cleared ZELTIQ Aesthetics Inc.'s CoolSculpting, a noninvasive fat-removal technology for upper arms.

The company will also launch the CoolAdvantage Petite applicator for the CoolSculpting system to optimize the performance of CoolSculpting in the upper arms, with full commercial release targeted for the middle of 2017.